The Russian Satellite Light Satellite Vaccine received approval for use in Iran. This is reported by the Russian Foundation for direct investment (RFI).
The Foundation states that the Ministry of Health of the Islamic Republic of Iran allowed the use of a vaccine in the country. Earlier, the Iranian government approved the use of a two-component vaccine “Satellite V”.
Previously, the preparation from the COVID-19 Satellite Light showed high efficiency in Argentina. According to the data provided (RFI), one-component drug has demonstrated effectiveness from 78.6 to 83.7 percent among citizens aged 60 to 79 years.
/Media reports.